Zane Yang

446 total citations
6 papers, 57 citations indexed

About

Zane Yang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Zane Yang has authored 6 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Zane Yang's work include Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (1 paper) and Neutropenia and Cancer Infections (1 paper). Zane Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), RNA modifications and cancer (1 paper) and Neutropenia and Cancer Infections (1 paper). Zane Yang collaborates with scholars based in United States. Zane Yang's co-authors include Shanta Chawla, Patrick Cobb, Richy Agajanian, Alvaro Restrepo, Lee S. Schwartzberg, Gajanan Bhat, Julio A. Peguero, Inderjit Mehmi, Jean Boyer and Sarina A. Piha‐Paul and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

Zane Yang

6 papers receiving 55 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zane Yang United States	4	40	20	17	14	13	6	57
Elizabeth Sirmans United States	3	38 0.9×	15 0.8×	5 0.3×	7 0.5×	10 0.8×	4	49
Salla Markkinen Finland	3	17 0.4×	14 0.7×	8 0.5×	7 0.5×	10 0.8×	4	53
Spartak Valev Bulgaria	3	47 1.2×	9 0.5×	20 1.2×	15 1.1×	9 0.7×	6	69
María Jesús Rubio-Pérez Spain	6	86 2.1×	31 1.6×	8 0.5×	15 1.1×	21 1.6×	15	137
Julie S. Deutsch United States	5	26 0.7×	12 0.6×	21 1.2×	3 0.2×	8 0.6×	9	43
Mahmoud Charif United States	4	30 0.8×	35 1.8×	9 0.5×	11 0.8×	3 0.2×	10	62
Zienab Etwebi United States	4	14 0.3×	28 1.4×	9 0.5×	10 0.7×	31 2.4×	9	71
E.M. Guerra Spain	4	43 1.1×	26 1.3×	5 0.3×	13 0.9×	11 0.8×	8	77
A. Winge-Main Norway	4	35 0.9×	30 1.5×	31 1.8×	5 0.4×	16 1.2×	7	72
Paula Podolski Croatia	4	21 0.5×	22 1.1×	11 0.6×	5 0.4×	23 1.8×	12	63

Countries citing papers authored by Zane Yang

Since Specialization

Citations

This map shows the geographic impact of Zane Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zane Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zane Yang more than expected).

Fields of papers citing papers by Zane Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zane Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zane Yang. The network helps show where Zane Yang may publish in the future.

Co-authorship network of co-authors of Zane Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zane Yang. A scholar is included among the top collaborators of Zane Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zane Yang. Zane Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Piha‐Paul, Sarina A., Seema Nagpal, Amy Weise, et al.. (2023). A phase 1, multicenter, open-label study of a new BRAF inhibitor ABM-1310 in adult patients (pts) with BRAFv600-mutated solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 3098–3098. 7 indexed citations

2.

Schwartzberg, Lee S., Gajanan Bhat, Julio A. Peguero, et al.. (2020). Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III Trial. The Oncologist. 25(8). e1233–e1241. 22 indexed citations

3.

Elamin, Yasir Y., Jacqulyne Robichaux, Mehmet Altan, et al.. (2019). MA09.03 Identification of Mechanisms of Acquired Resistance to Poziotinib in EGFR Exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 14(10). S282–S283. 13 indexed citations

4.

Robichaux, Jacqulyne, Yasir Y. Elamin, Zhi Tan, et al.. (2018). Abstract 4772: Poziotinib overcomes de novo resistance of HER2 exon 20 mutations in NSCLC and other cancers: Preclinical studies and initial clinical testing. Cancer Research. 78(13_Supplement). 4772–4772. 1 indexed citations

5.

Aggarwal, Charu, Roger Cohen, Matthew P. Morrow, et al.. (2015). Immunotherapy with VGX-3100 (HPV16 and HPV18 plasmids) + INO-9012 (DNA encoding IL-12) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa): interim safety and immunogenicity results. Journal for ImmunoTherapy of Cancer. 3(S2). 12 indexed citations

6.

Crawford, E. David, Philip W. Kantoff, Neal D. Shore, et al.. (2015). MP73-12 UNSUSPECTED METASTASES FOUND DURING SCREENING FOR A TRIAL OF PATIENTS WITH NON-METASTATIC CASTRATION RESISTANT PROSTATE CANCER. The Journal of Urology. 193(4S). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact